ContactPrint • DisclaimerTerms & Conditions

Recent Publications

News

  • Cappable-seq Service now available !

    In close cooperation with New England Biolabs, Inc. (NEB), VERTIS is now able to make the new Cappable-seq method available to its customers. The method was developed by Laurence Ettwiller and Ira Schildkraut from NEB (Ettwiller, L. et al. 2016. BMC Genomics. 17, 1 (2016), 199).

    It represents the current most sensitive and robust method for the precise identification of bacterial transcription start sites (TSSs).

vertis Biotechnologie AG
Lise-Meitner-Str. 30
D-85354 Freising
Germany

Fon +49-(0)8161-18516-11
Fax +49-(0)8161-18516-12

Contact FormHow to find us

Disclaimer

This Site is provided by:

vertis Biotechnologie
Lise-Meitner-Str. 30
85354 Freising
Germany

Phone: +49 8161 18516 11

Fax: +49 8161 18516 12

E-Mail: info@vertis-biotech.com
Web: www.vertis-biotech.com

Managing Director:
Dr. Fritz Thümmler

Commercial court: Munich, Germany
Companies register number: HRB 131415

Sales Tax ID: DE 212301309

Terms and conditions:
Although we have attempted to provide accurate information on the Site, we assume no responsibility for the accuracy of the information of third party sites. VERTIS Biotechnologie AG does not warrant the adequacy, currency, accuracy, or completeness of the information and materials of third party sites linked to or from this Site nor that the functions provided will be uninterrupted or error-free. VERTIS Biotechnologie AG expressly disclaims any liability for any errors in or omissions in the content of any third-party sites linked to or from this Site.